MY184865A - Novel bacillus subtilis - Google Patents

Novel bacillus subtilis

Info

Publication number
MY184865A
MY184865A MYPI2014702921A MYPI2014702921A MY184865A MY 184865 A MY184865 A MY 184865A MY PI2014702921 A MYPI2014702921 A MY PI2014702921A MY PI2014702921 A MYPI2014702921 A MY PI2014702921A MY 184865 A MY184865 A MY 184865A
Authority
MY
Malaysia
Prior art keywords
bacillus subtilis
novel bacillus
same
novel
kccm11271p
Prior art date
Application number
MYPI2014702921A
Inventor
Seung Hee Back
Si Yong Yang
Seo Hyung Woo
Hyo Seel Seo
Original Assignee
Cj Cheiljedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Cheiljedang Corp filed Critical Cj Cheiljedang Corp
Publication of MY184865A publication Critical patent/MY184865A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

The present invention relates to a novel Bacillus subtilis CJMPB957 (KCCM11271P) strain, a probiotic formulation containing the same, and a method for preventing or treating a disease in livestock by using the same. Figure 1
MYPI2014702921A 2012-04-05 2013-04-04 Novel bacillus subtilis MY184865A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120035289A KR101370942B1 (en) 2012-04-05 2012-04-05 Novel Bacillus subtilis
PCT/KR2013/002827 WO2013151362A1 (en) 2012-04-05 2013-04-04 Novel bacillus subtilis

Publications (1)

Publication Number Publication Date
MY184865A true MY184865A (en) 2021-04-28

Family

ID=49300777

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014702921A MY184865A (en) 2012-04-05 2013-04-04 Novel bacillus subtilis

Country Status (5)

Country Link
JP (1) JP5998273B2 (en)
KR (1) KR101370942B1 (en)
MY (1) MY184865A (en)
PH (1) PH12014502243A1 (en)
WO (1) WO2013151362A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2869036C (en) * 2012-04-13 2021-06-08 Chr. Hansen A/S Antibiotic sensitive bacillus strains having antimicrobial effect against e. coli and clostridium perfringens and having high sporulation capacity
KR101661745B1 (en) * 2014-09-15 2016-10-04 녹십자수의약품(주) Composition comprising novel bacillus subtilis GCB-13-001 having enzymatic profile for treating or preventing Clostridium sp. bacterial toxin
MX2018014476A (en) * 2016-05-31 2019-04-29 Evonik Degussa Gmbh Bacillus subtilis strain with probiotic activity.
US11173184B2 (en) 2016-05-31 2021-11-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
KR101865177B1 (en) * 2016-11-25 2018-06-08 롯데제과 주식회사 Bacillus subtilis LRCC1002 strain having enzymatic profile, bile resistance, antimicrobial activity for Helicobacter Pylori, and thrombolysis activity
CN107691348A (en) * 2017-09-19 2018-02-16 郝天伟 A kind of cultural method of low fat reed catkins chicken
WO2019093611A1 (en) 2017-11-10 2019-05-16 (주)앰틱스바이오 Novel pediococcus pentosaceus ab 160011 strain and composition containing same
KR102005434B1 (en) 2018-02-22 2019-07-30 강원대학교산학협력단 Bacillus subtilis AF11 against Aspergillus flavus strain producing aflatoxin
KR102015823B1 (en) * 2018-05-28 2019-10-23 (주)에코비즈넷 Bacillus subtilis EBN-YR47 having excellent inhibitory activity against mycotoxin-producing fungi
CN109924350A (en) * 2019-04-04 2019-06-25 河南鑫牧生物科技有限公司 A kind of feed addictive and preparation method thereof releasing mycotoxin
CN116024146B (en) * 2023-03-28 2023-06-27 中国农业大学 Bacillus subtilis with high antibacterial activity and fermentation condition optimization thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100621657B1 (en) * 2004-04-23 2006-09-19 주식회사 유니바이오테크 New Bacillus subtilis UBT-M02 strain which has an acid and bile acid resistances, feed additive composition using it, and feed of animal having thereof
KR100850743B1 (en) * 2006-12-07 2008-08-06 (주)셀텍 Bacillus subtilis and Probiotics Using the Same
KR20090066410A (en) * 2007-12-20 2009-06-24 (주) 비엔씨바이오팜 Composition for forage additive comprising bacillus subtilis bc1212
KR101190901B1 (en) * 2010-06-14 2012-10-12 몽고식품 주식회사 Bacillus subtilis CSY191 strain and probiotics containing the strain
KR101201184B1 (en) * 2010-06-29 2012-11-13 몽고식품 주식회사 A novel bacillus subtilis strain, and probiotics and low biogenic amine containing food by using the strain

Also Published As

Publication number Publication date
WO2013151362A1 (en) 2013-10-10
PH12014502243B1 (en) 2014-12-15
KR101370942B1 (en) 2014-03-12
JP2015513910A (en) 2015-05-18
KR20130113037A (en) 2013-10-15
PH12014502243A1 (en) 2014-12-15
JP5998273B2 (en) 2016-09-28

Similar Documents

Publication Publication Date Title
MY184865A (en) Novel bacillus subtilis
PH12018501711A1 (en) Compounds for treating spinal muscular atrophy
MX352962B (en) Compounds for treating spinal muscular atrophy.
MX358514B (en) Compounds for treating spinal muscular atrophy.
PH12014502704B1 (en) Compounds and compositions for modulating egfr activity
JO3343B1 (en) Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use
MX359327B (en) Methods and compositions for treating huntington's disease.
PH12015501273B1 (en) Probiotic strains for the treatment and/or prevention of diarrhea
MX2016009241A (en) Methods of reducing malodor and bacteria.
PH12018500368A1 (en) Preparations containing amorphous emodepside
MX2013013649A (en) Quinone compounds for treating ape1 mediated diseases.
PH12019500264A1 (en) Lactobacillus salivarius cjls1511, animal feed additive composition comprising same bacterium or dead cells thereof, and method for producing same dead cells
WO2014033574A3 (en) Protein stabilized probiotics and personal care products
MY174997A (en) Novel separated bacillus licheniformis and probiotics using same
MX349563B (en) Pharmaceutical formulation of nanonised fenofibrate.
IN2015DN02645A (en)
SG178967A1 (en) Antimicrobial compositions and products
IN2014DN07191A (en)
MY180716A (en) Novel separated bacillus licheniformis and probiotics using same
MX2015004316A (en) Flavor and fragrance formulation (iv).
MY178699A (en) A bacteria strain for treatment of cocoa tree disease
UA105703C2 (en) 7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzdiazepin-2-ones as analgetic agents
UA56040U (en) 1,3-dimethyl-7-n-chlorobenzene-8-n-bromobenzylidene hydrazinoxanthine exhibiting diuretic and anti-oxidant action
UA102047C2 (en) USE OF STRAIN OF RELIC BACTERIA BACILLUS sp. F AS HEPATOPROTECTOR AND ANTIOXIDANT
UA77230U (en) amprolev complex treatments for heteracoso-histomonosis invasion of poultry